Tomorrow is the end Notable’s 10-week campaign to raise funds for the Leukemia & Lymphoma Society.
We’re only $20K away from our goal of $200K.
What does $200K of LLS funding mean?
- 4 years of research funding for scientists and doctors
- Educational programs for 3,000 patients and caregivers
- General financial assistance for 1,300 blood cancer patients with significant financial need
- 4,000 tissue typing tests for bone marrow donor matching
Please donate here: https://bit.ly/2JP7KAV
Thank you for your support!
— Pete and Team Notable
Entering the tenth and final week of the 2018 Leukemia & Lymphoma Society Man & Woman of the Year fundraising campaign, it seems only fitting that a friend would coincidentally send me a beautiful short film about a South African surfer, Adam Voigt, who was diagnosed with Chronic Myeloid Leukemia (CML).
As a fellow (aspiring) surfer I was touched by Adam’s story and the film made me reflect on some of the amazing individuals I’ve connected with over the course of the ten…
San Francisco, California —Over 30 top Silicon Valley, New York City, and Los Angeles venture capital investors are joining Notable Labs to help raise funding and awareness for the Leukemia & Lymphoma Society (LLS) through the “2018 VC Master Lunch Auction Series.” The virtual auction hosted on Charitybuzz will offer bidders the opportunity to meet, pitch, and strategize one-on-one with legendary investors. Bidding is now open on CharityBuzz at https://www.charitybuzz.com/support/LLSVCAuction. The VC auctions run between now and June 1.
David Lee, a…
With 4 weeks left in our Leukemia & Lymphoma Society (LLS) fundraising campaign, we have some great news to share!
Last week at the American Society of Pediatric Hematology (ASPHO) annual conference in Pittsburgh, PA, Notable Labs co-presented exciting data from an ongoing research collaboration with Rady Children’s Hospital in San Diego.
In the research collaboration Notable’s platform is being used to generate data around potential sensitivity to FDA-approved drugs for relapsed and refractory pediatric acute myeloid leukemia (AML) patients.
With 6 weeks left in the Leukemia & Lymphoma Society Man/Woman of the Year campaign, Team Notable is 1/4 of the way to our fundraising goal! Thank you to all that have supported us thus far.
This week, I’d like to highlight three special members of Team Notable who are not only generously donating their time to fundraise for LLS, they themselves are amazing hematology oncology clinician researchers in the Bay Area.
Dr. Alex Aleshin, Stanford: Adult Hematology Oncologist focused on myleodyplastic syndromes (MDS).
Dr. Elliot Stieglitz, UCSF: Pediatric Hematology Oncologist focused on juvenile myelomonocytic leukemia (JMML).
With 7 weeks left in our campaign to raise funding for the Leukemia & Lymphoma Society, we have some exciting news to share!
Last week Marianne, Matt, and Omid traveled to Chicago for the 2018 American Association for Cancer Research (AACR) conference, the largest cancer research conference of the year. We were honored to present alongside collaborators at Stanford (Drs. Alex Aleshin, Bruno Medeiros, Savita Kamble and Peter Greenberg) our proof-of-concept data utilizing Notable Labs’ platform to identify drug sensitivity and resistance in myelodysplastic syndromes (MDS).
We’re also thrilled to have Dr. Aleshin actively participating in Team Notable’s fundraising efforts…
In case you haven’t been following along for the last couple weeks here and here, Notable Labs and I are campaigning for the Leukemia & Lymphoma Society to raise funding for blood cancer research and treatments.
WHY SUPPORT BLOOD CANCER RESEARCH? Approximately every three minutes one person in the United States is diagnosed with a blood cancer. There are currently no preventative measures or means to screen for blood cancer, therefore, we need to fund research to find cures.
THIS WEEK’S UPDATE — SAVE THE DATE: Short and sweet. The Leukemia & Lymphoma Society Man/Woman of the Year 10-week fundraising…
MEET ARIANA
Last week was the kickoff to the Leukemia & Lymphoma Society’s 10-week campaign to raise funds for blood cancer research. At the kickoff event I met Ariana.
Ariana was diagnosed with B-cell acute lymphoblastic leukemia (ALL) in February 2015, when she was only three and a half years old. What was first thought to be a bad case of the flu quickly became a series of hospitalizations, lumbar punctures, bone marrow aspirates, chemotherapy appointments, blood draws, steroids, hair loss, and isolation from friends and classmates.
Despite these challenges, Ariana fought her cancer with a smile and after 27…
The past four years I’ve been working alongside my teammates at Notable Labs to change the way that cancer is treated by putting patients first.
Today I’m asking you to support patients, my teammates, and our clinical and research partners as we join Leukemia and Lymphoma Society fundraising to find cures for blood cancers.
WHY SHOULD YOU SUPPORT BLOOD CANCER RESEARCH?
As you may or may not know, research in blood cancers has paved the way for groundbreaking insights, treatments, and cures across many different types of cancers. …
Notable Labs
Changing the way cancer is treated by putting patients first
